Another approach has been to add a ligand such as biotinylated epidermal growth factor (EGF) to streptavidin-nanocrystals at sub-stoichiometric ratios, such that most nanocrystals bind no EGF, some bind one EGF, and almost none bind two EGF molecules (Lidke, D. S., et al. (2005).